Insider Transactions in Q2 2025 at I Teos Therapeutics, Inc. (ITOS)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 10
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
137,910
+50.0%
|
$551,640
$4.3 P/Share
|
Jun 10
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,400
+7.99%
|
$105,600
$4.3 P/Share
|
Jun 10
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
43,883
-100.0%
|
$438,830
$10.02 P/Share
|
Jun 10
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,400
-5.82%
|
$84,000
$10.02 P/Share
|
Jun 09
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
43,882
-100.0%
|
$438,820
$10.03 P/Share
|
Jun 09
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
43,882
+50.0%
|
$175,528
$4.3 P/Share
|
Jun 09
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,400
-5.82%
|
$84,000
$10.03 P/Share
|
Jun 09
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,400
+5.5%
|
$33,600
$4.3 P/Share
|
Jun 06
2025
|
David Hallal |
SELL
Open market or private sale
|
Direct |
38,228
-100.0%
|
$382,280
$10.24 P/Share
|
Jun 06
2025
|
David Hallal |
BUY
Exercise of conversion of derivative security
|
Direct |
38,228
+50.0%
|
$152,912
$4.3 P/Share
|
Jun 06
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
43,882
-100.0%
|
$438,820
$10.21 P/Share
|
Jun 06
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
43,882
+50.0%
|
$175,528
$4.3 P/Share
|
Jun 06
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,400
-5.82%
|
$84,000
$10.21 P/Share
|
Jun 06
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,400
+5.5%
|
$33,600
$4.3 P/Share
|
Jun 05
2025
|
David Hallal |
SELL
Open market or private sale
|
Direct |
38,227
-100.0%
|
$382,270
$10.15 P/Share
|
Jun 05
2025
|
David Hallal |
BUY
Exercise of conversion of derivative security
|
Direct |
38,227
+50.0%
|
$152,908
$4.3 P/Share
|
Jun 05
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
43,882
-100.0%
|
$438,820
$10.15 P/Share
|
Jun 05
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
43,882
+50.0%
|
$175,528
$4.3 P/Share
|
Jun 05
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,400
-5.82%
|
$84,000
$10.15 P/Share
|
Jun 05
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,400
+5.5%
|
$33,600
$4.3 P/Share
|
Jun 04
2025
|
David Hallal |
SELL
Open market or private sale
|
Direct |
38,227
-100.0%
|
$382,270
$10.07 P/Share
|
Jun 04
2025
|
David Hallal |
BUY
Exercise of conversion of derivative security
|
Direct |
38,227
+50.0%
|
$152,908
$4.3 P/Share
|
Jun 04
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
43,883
-100.0%
|
$438,830
$10.1 P/Share
|
Jun 04
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
43,883
+50.0%
|
$175,532
$4.3 P/Share
|
Jun 04
2025
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,400
-5.82%
|
$84,000
$10.1 P/Share
|
Jun 04
2025
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,400
+5.5%
|
$33,600
$4.3 P/Share
|
May 15
2025
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,300,000
+23.59%
|
$26,400,000
$8.0 P/Share
|
May 14
2025
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,658,978
+18.34%
|
$11,612,846
$7.41 P/Share
|
May 13
2025
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
630,191
-23.01%
|
$5,041,528
$8.06 P/Share
|
May 13
2025
|
Mpm Bioventures 2018, L.P. |
SELL
Open market or private sale
|
Indirect |
630,191
-23.01%
|
$5,041,528
$8.06 P/Share
|
May 13
2025
|
Ansbert Gadicke |
SELL
Open market or private sale
|
Indirect |
1,031,931
-23.01%
|
$8,255,448
$8.06 P/Share
|
May 13
2025
|
Timothy Van Hauwermeiren |
BUY
Exercise of conversion of derivative security
|
Direct |
22,346
+50.0%
|
$89,384
$4.3 P/Share
|